The deal will have GlaxoSmithKline plc (ADR) buying Novartis’ 36.5% stake in the Consumer Healthcare Joint Venture. This will have GSK taking over full ownership of the Consumer Healthcare business. GlaxoSmithKline plc (ADR) says …
Shares of GlaxoSmithKline plc (GSK,GSK.L) were gaining around 6 percent in the morning trading in London after the British drug major announced Tuesday that it has reached an agreement to buyout Swiss drug maker Novartis' (NVS) …
Horlicks Ltd held 43.16% stake in GSK Consumer Healthcare Ltd as of December 2017, according to the Bombay Stock Exchange.\ GSK expects the outcome of the strategic review to be concluded around the end of 2018, the company …
LONDON (Reuters) - Britain’s Orchard Therapeutics, which has already raised more than $140 million (98.54 million pounds) to fund its work in gene therapy, plans another private sale of shares following its acquisition of a portfolio of …
GSK Consumer Healthcare Ltd., (GSK) a public listed company on the Bombay Stock Exchange and National Stock Exchange, is an associate of GlaxoSmithKline. The strategic review will include an assessment of GSK’s 72.5% …
GlaxoSmithKline plc (ADR) (NYSE:GSK) shares were soaring Friday as the company announced that it is no longer in the running to buy some of Pfizer Inc.’s (NYSE:PFE) assets. The company was considered to be the frontrunner to …
LONDON (Reuters) - Britain’s Orchard Therapeutics, which has already raised more than $140 million to fund its work in gene therapy, plans another private sale of shares following its acquisition of a portfolio of GlaxoSmithKline (GSK.L) …